Crossmark

Antibody-drug conjugates: integrated bioanalytical and biodisposition assessments in lead optimization and selection

Crossref DOI link: https://doi.org/10.1186/s41120-018-0026-0

Published Online: 2018-08-08

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Beaumont, Maribel

Tomazela, Daniela

Hodges, Douglas

Ermakov, Grigori

Hsieh, Edward

Figueroa, Isabel

So, On-Yee

Song, Yaoli

Ma, Huiping

Antonenko, Svetlana

Mengesha, Wondwessen

Zhang, Yi Wei

Zhang, Shuli

Hseih, SuChun

Ayanoglu, Gulesi

Du, Xiaoyan

Rimmer, Eric

Judo, Michael

Vives, Franklin

Yearley, Jennifer H.

Moon, Christina

Manibusan, Anthony

Knudsen, Nick

Beck, Andy

Bresson, Damien

Gately, Dennis

Neupane, Divas

Escandón, Enrique http://orcid.org/0000-0002-2297-969X
Funding

Funding for this research was provided by:

Merck
License Information

Text and Data Mining valid from 2018-08-08
More Information

Article History

Received: 27 February 2018

Accepted: 10 July 2018

First Online: 8 August 2018

Competing interests

: All authors are current or former employees of Merck & Co., Inc. or Ambrx, Inc. The authors declare no competing financial interest.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.